---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-174318"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2024-07-02T23:59:59+00:00"
generated_at: "2026-05-31T23:49:27.501772+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Appoints David Johnson as COO effective July 1, 2024

## Summary
- David Johnson named COO; previously Chief Commercial Officer at Global Blood Therapeutics.
- Annual base salary of $500,000; eligible for bonus up to 40% of base salary.
- Granted option to purchase 160,000 shares at $36.29, vesting over 4 years.
- Severance: 9 months salary without change in control; 12 months with change in control.
- Johnson also receives up to $10,000 reimbursement for legal fees related to offer letter.

## SEC filing metadata
- accession: 0001193125-24-174318
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2024-07-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312524174318/0001193125-24-174318-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312524174318/d799103d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-174318
- JSON: https://secwatch.observer/filing/0001193125-24-174318.json
- Plain text: https://secwatch.observer/filing/0001193125-24-174318.txt

## Source-grounded claims
- claim_id: a891795c58
  claim: David Johnson was appointed as Chief Operating Officer at Vera Therapeutics, Inc..
  evidence_excerpt: On July 1, 2024, Vera Therapeutics, Inc. (the “ Company ”) announced the appointment of David Johnson as the Company’s Chief Operating Officer, effective July 1, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831828/000119312524174318/0001193125-24-174318-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.